Auro Nair, Ph.D., M.B.A.

Executive Vice President of The Jackson Laboratory and President, JAX® Mice, Clinical and Research Services

Strategic and operational leader of JMCRS, commercial arm of JAX serving the global biomedical research and drug development community


Farmington, CT




Auro Nair, executive vice president of The Jackson Laboratory and president, JAX® Mice, Clinical and Research Services (JMCRS), joined The Jackson Laboratory in 2007 as associate general manager of JAX ® Mice and Services. Since then, with a focus on innovation and customer experience, he led the expansion of JMCRS into an enterprise that is six times larger than it was when Nair joined. This growth includes the establishment of new sites in Sacramento, California and Ellsworth, Maine, the development and launch of leading-edge preclinical services enabling biopharma drug development and the creation of clinical services under Nair’s leadership. Following multiple promotions, Nair was named the first president of JMCRS in 2017 and was also promoted to executive vice president of The Jackson Laboratory in 2018. Nair has driven the international expansion of JMCRS, most recently through the establishment of JAX’s first joint venture company in China in November 2020 and the acquisition of Charles River Japan in October 2021. Currently Nair serves as the chairman of the board for both of these international organizations. In recognition of his leadership impact, Nair was named as a co-honoree of The Robert Alvine Family Endowed Chair that was established by Robert Alvine, chair emeritus of the JAX Board of Trustees.

Throughout his career Nair has progressed through various commercial leadership positions since joining Zymark in 1997 as director of business development. Nair then served as vice president for worldwide marketing and North American sales with Caliper Life Sciences (now part of PerkinElmer) in Hopkinton, Massachusetts where he led the launch of multiple new products and services before joining The Jackson Laboratory.

From 1990 to 1997 Nair served in positions of increasing scientific and technical management responsibility at GlaxoSmithKline’s FDA-approved site in Singapore, ultimately managing all Quality Compliance and Analytical Services.

Nair is a graduate in chemistry of the University of Science, Penang, Malaysia; holds a Ph.D. in chemistry from the University of Oklahoma, Norman; and has an executive MBA from Suffolk University in Boston, Massachusetts.